News

News

01 Sep 2022
Epigeneron and Axcelead DDP singed a master collaboration agreement on drug discovery research for novel drug targets

News

28 Feb 2022
Epigeneron, Inc. and Brain Research Institute, Niigata University started joint research on novel drug target discovery research for neurodegenerative diseases

24 Nov 2021
Epigeneron, Inc. and Center for Genomic and Regenerative Medicine, Juntendo University School of Medicine started a joint research on novel drug target discovery for neurodegenerative diseases.

News

22 Sep 2021
One of the founders of Epigeneron, Inc., Toshitsugu Fujita, Ph.D. received Bioindustry Research Award 2021.

03 Sep 2021
FUJIFILM Wako Pure Chemical Corporation was designated as one of the distributors of the ORNi-PCR related products.

02 Sep 2021
Multi-projects collaboration with Sygnature Discovery has been initiated.

News

19 Aug 2021
A new scientific paper by Dr. Hodaka Fujii, the Founder and CSO of the company, has been published.

News

01 Aug 2021
A new R&D Director was appointed.

01 Aug 2021
WAKENYAKU CO.,LTD. was designated as one of the distributors of the ORNi-PCR related products.

News

13 Jul 2021
A new patent on ORNi-PCR has been granted by the Japanese authority.

News

09 Jul 2021
A new scientific paper by Dr. Hodaka Fujii, the Founder and CSO of the company, has been published.

News

22 Jun 2021
A new patent on ORNi-PCR has been granted by the Korean authority.

News

27 Apr 2021
A new patent on ORNi-PCR has been granted by the Canadian authority.

News

19 Apr 2021
A new scientific paper by Dr. Hodaka Fujii, the Founder and CSO of the company, has been published.

News

12 Apr 2021
A new patent on ORNi-PCR has been granted by the Israeli authority.